VALERIE LAVOIE: Open Payments
NPI 1639583099 · GREENSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$829 in 35 payments from 9 companies in 2025. Trend: 2023 $975 · 2024 $756 · 2025 $829
Food & beverage: $829
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $358 |
| Neurocrine BioSciences, Inc. | 2 | $126 |
| Bausch Health US, LLC | 5 | $93 |
| Lundbeck LLC | 3 | $66 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $53 |
| Otsuka America Pharmaceutical, Inc. | 2 | $44 |
| Alkermes, Inc. | 2 | $35 |
| Janssen Pharmaceuticals, Inc | 2 | $35 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: VRAYLAR, INGREZZA, APLENZIN, REXULTI, CAPLYTA, SPRAVATO, ABILIFY MAINTENA, UZEDY.
Industry payments across NC — which companies pay providers there.
